home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Design History Files and Technical Files/Design Dossiers - Meeting U.S. FDA CGMPS and the EU's MDD Requirements

 
  October 07, 2013  
     
 
ComplianceOnline, Online Event
2013-11-06


Why Should You Attend:

Global companies must meet different product design documentation for the U.S. and the European Union / Common Market.  The cGMPs mandate Design Control and the Design History File (DHF).  In order to sell globally, the EU's CE-marking documentation is a requirement -- the Technical File or Design Dossier.  Currently they serve different purposes, support different goals, but the TF/DD is moving in the direction of the DHF. And the DHF may soon borrow some features required in the TF/DD.  Being aware of the similarities and differences can further concurrent development / documentation, and/or updates to both.  What are DMRs and DHRs relationship to DHFs, TF/DDs?

This webinar will examine the existing and proposed requirements for the FDA's DHF and the MDD's TF/DD -- how to meet and document them.  Their differing purposes / goals, required and desirable contents and areas requiring frequent re-evaluation / update will be discussed. Similarities and differences, and future convergences and trends will be examined. Typical DHF Table of Contents, Technical File or Design Dossier Table of Contents will be presented.

The importance and usefulness of the "Essential Requirements".  Structure of the "Declaration of Conformity"; self-declaring or N-B reviewed.  We will also discuss parallel approaches to development, the Device Master Record / Device History Record "tie in" and  differing approaches to file audits by the U.S. FDA and a Notified Body.

Areas Covered in the Seminar:

  • The U.S. FDA's DHF
  • The EU's MDD and the Technical File / Design Dossier
  • Design Control 'Over Time' vs. a Product 'Snapshot in Time'
  • DHF "Typical" Contents
  • TF / DD Expected Contents
  • Parallel Approaches to Documentation -- Teams
  • The DMR and DHR -- DHF "Deliverables"
  • Some Future Trends to Consider
  • FDA and NB Audit Focus
 
 
Organized by: ComplianceOnline
Invited Speakers: John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 31 years experience in U.S. FDA-regulated industries, 17 years as a full-time consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan.
 
Deadline for Abstracts: 2013-11-06
 
Registration: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=701898?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.